Delivery Order SPE2DB22D1106-SPE2DB25FELA2

Award Date 4/29/25
Potential Completion Date 4/30/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, SPE2DB22D1103|SPE2DB25FTHD9, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,177.02 firm-fixed-price delivery order contract covers the provision of Lyrica 25 mg capsules. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,911.60 firm fixed-price delivery order contract is for the provision of Lyrica 50 mg capsules. The contract has an ultimate completion date of February 3, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, with ID SPE2DB20D2104|SPE2DB24FU14T, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,708.69 firm fixed-price delivery order contract is for the provision of Lyrica 75 mg capsules. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, with ID SPE2DB20D1100|SPE2DB25FB8Y2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,071.38 delivery order contract is for the supply of 90-count capsules of the prescription medication Lyrica 50 mg. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 24, 2025. AmerisourceBergen Drug Corp holds a substantial...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,233.34 firm fixed-price delivery order is for the supply of Lyrica 300 mg capsules. The contract has an ultimate completion date of January 7, 2025 and was awarded on January 6, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,491.29, is a Firm Fixed Price Delivery Order for the supply of Lyrica 150 mg Capsules. The contract has an ultimate completion date of September 25, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award, with ID SPE2DB22D1017|SPE2DB24FF0FZ, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lyrica 50 mg capsules, a pharmaceutical product, with a ceiling value of $3,587.94 and a completion date of December 26, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,928.80 firm fixed price delivery order contract covers the supply of Lyrica 25 mg capsules to support military healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lyrica 150 mg capsules. The $5,241.11 firm-fixed-price contract has an ultimate completion date of August 28, 2024 and was awarded on August 27, 2024. It is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, identified as SPE2DB20D1100|SPE2DB24FZ75F, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,471.00 firm fixed-price delivery order covers the supply of Lyrica 50 mg capsules, a medication used for various medical conditions. The contract has an ultimate completion date of January 18, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FELA2
    Delivery Order

This federal contract award, SPE2DB22D1106|SPE2DB25FELA2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm-fixed price for the supply of Lyrica 225 mg capsules. The award has a ceiling value of $1,203.12 and an ultimate completion date of April 30, 2025. The contract is not set-aside and is open to competition.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This prime contract, designated as SPE2DX, provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. The IDC enables the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 7/29/25, 9:53 AM